XML 17 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Net Sales $ 72,810 $ 61,931
Cost of Sales 68,733 64,351
Gross (Loss) Profit 4,077 (2,420)
Research and Product Development 3,119 6,835
Selling and Marketing 2,094 5,733
General and Administrative 15,644 15,348
Operating Loss (16,780) (30,336)
Other Expense    
Realized Gain on Investments 4 0
Interest Expense (1,936) (2,360)
Interest Income 33 22
Total Other Expense (1,899) (2,338)
Net Loss $ (18,679) $ (32,674)
Net Loss per Share, Diluted (in dollars per share) $ (1.89) $ (3.83)
Net Loss per Share, Basic (in dollars per share) $ (1.89) $ (3.83)
Weighted Average Shares Outstanding, Diluted (in shares) 9,866,844 8,526,186
Weighted Average Shares Outstanding, Basic (in shares) 9,866,844 8,526,186